Metabolic and Endocrine Effects of Combination of Metformin and DPP-4 Inhibitor Saxagliptin Compared to Saxagliptin or Metformin XR Monotherapy in Patients With PCOS and Impaired Glucose Regulation: A Single-blinded Randomized Pilot Study
Phase of Trial: Phase III
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Saxagliptin/metformin (Primary) ; Metformin; Saxagliptin
- Indications Hyperglycaemia
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Acronyms BMS-AZPCOS
- 31 Oct 2016 Status changed from active, no longer recruiting to completed.
- 22 Aug 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.
- 22 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Oct 2016.